Breast Biopsy: Stereotactic and Ultrasound Guidance (Jun, 2019)

Breast Biopsy: Stereotactic and Ultrasound Guidance is organized by Medical Technology Management Institute (MTMI) and will be held from Jun 21 - 22, 2019 at Mammotome, Cincinnati, Ohio, United States of America.

Audience:
This course is useful for professionals involved in women’s imaging services including radiologists, physicians, technologists, mammographers, sonographers, breast biopsy coordinators, breast health clinicians, nurses and medical imaging managers.

CME:
The Medical Technology Management Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Medical Technology Management Institute designates this live activity for a maximum of 16.00 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

ASRT Category A:
This program provides 8.5 hours of Category A continuing education credit for radiologic technologists approved by ASRT and recognized by the ARRT and various licensure states.  Category A credit is also recognized by CAMRT’s Continuing Education Credit Approval Program for CE credit in Canada.  You must attend the entire program to receive your certificate of completion.  

This credit designation is for each day.
• 8.5 hours of credit for each day.
• Biennium CE Credits: 8.5
• Structured Education / CQR Credits: 8

Nursing CBRN:
Provider approved by the California Board of Registered Nursing, Provider Number CEP# 16205 for 8 contact hours.

This credit designation is for each day.

Description:
Stereotactic and ultrasound breast biopsy are used to obtain pathologic information from mammographic areas of suspicion. When a mass, microcalcifications, or area of abnormal tissue change exist; stereotactic and ultrasound breast biopsy offers a minimally invasive alternative to open surgical biopsy, often before a mass develops.

This course offers the attendee the opportunity to learn the basics, as well as the tricks of the trade, from experienced instructors with multi-vendor competence. Our instructors are excited and willing to share this knowledge to help bridge the gaps in training, so that intelligent performance becomes your daily mode of operation. Supervised simulation and hands-on training with phantoms, live-models, and biopsy devices make this course refreshingly unique.

Critical thinking becomes possible once attendees develop an understanding of why and how these procedures are done rather than “this is how we have always done it”. In addition to covering quality assurance and patient documentation, the two day course reviews the ACR and ASBrS accreditation requirements and fulfills the credits required for accreditation.

Educational Objectives:
At the completion of this course, participants will be able to:

• Explain and provide an overview of biopsy options for detection of breast cancer.
• Discuss the differences in biopsy needles and stereo tables.
• Clarify the difference between polar and Cartesian coordinate systems.
• Describe the components of the stereo images and how they work together.
• Demonstrate the importance of needle position in correlation to the area of interest in stereotactic breast biopsy procedures.
• Formulate problem solving skills when faced with difficult scenarios in breast biopsy techniques.
• Demonstrate proper patient positioning for stereotactic biopsy procedures.
• Review the importance of QA , ACR and ASBrS  requirements to help improve patient care and daily maintenance of your center.
• Review breast ultrasound algorithm and terminology.
• Review ultrasound and mammographic correlation
• Demonstrate how to use ultrasound equipment and minimally invasive techniques to accomplish ultrasound guided breast biopsy procedures.
• Discuss the importance of accurate tissue samples for the most precise diagnosis
• Identify high quality tissue and why it leads to high quality diagnosis.
• Explain artifacts that can lead to inconclusive results.